No. Patients on phase II or phase III clinical trials most often receive standard care treatments or newer but established as safe treatments. Such clinical trials are highly regulated and controlled.
No. Patients on phase II or phase III clinical trials most often receive standard care treatments or newer but established as safe treatments. Such clinical trials are highly regulated and controlled.